Friday Reading

• 举报此文章

Jason Shafrin

Jason Shafrin

Senior Managing Director, Center for Healthcare Economics & Policy at FTI Consulting; Adjunct Professor, University of Southern California

发布日期: 2021年10月8日

+ 关注

• Favorite paper.
• Covered California’s out-of-pocket drug max
• Google moves to first price auction.
• FDA on RWD for regulatory decision-making.
• NBA and health care fraud.

Originally posted at Healthcare Economist.

要查看或添加评论，请登录

Jason Shafrin的更多文章

• The Elasticity of Pharmaceutical Innovation

  2025年3月19日

  The Elasticity of Pharmaceutical Innovation

  That is the title of a new USC white paper by Darren Filson, Karen Van Nuys, Darius Lakdawalla and Dana Goldman with…

  17
• Number of US caregivers increases from 18 to 24 million

  2025年3月18日

  Number of US caregivers increases from 18 to 24 million

  That is according to a paper by Wolff et al. (2025).

  14
• NHS England will be abolished

  2025年3月14日

  NHS England will be abolished

  As reported by the BBC: NHS England will be abolished and brought under "democratic control" in an attempt to cut…

  23
• What is the Critical Medicines Act?

  2025年3月13日

  What is the Critical Medicines Act?

  On Tuesday (11 March 2025) the European Commission presented the draft of its new Critical Medicines Act (CMA). The…

  4
• Why are U.S. healthcare costs so high?

  2025年3月13日

  Why are U.S. healthcare costs so high?

  The Incidental Economist website has a helpful explainer video. The truth is that higher cost is due to both higher…

  22
• Do US commercial payers consider HTA and economic evidence when making coverage decisions?

  2025年3月10日

  Do US commercial payers consider HTA and economic evidence when making coverage decisions?

  That is the question asked in a new paper by Enright, et al. (2025).

  82

  5 条评论
• Calculating Social Vulnerability Index by ZIP Code

  2025年3月7日

  Calculating Social Vulnerability Index by ZIP Code

  A paper by Ng, Zhang and Kowal (2025) use the American Community Survey (ACS) data from 2016–2022 were used to…

  144

  6 条评论
• Value-Based Pricing for Drugs With Uncertain Clinical Benefits

  2025年3月6日

  Value-Based Pricing for Drugs With Uncertain Clinical Benefits

  This is the title of a recent paper by Jiao et al. (2025).

  73

  2 条评论
• About face for RFK Jr. on MMR vaccine?

  2025年3月4日

  About face for RFK Jr. on MMR vaccine?

  Last month, I noted that the decrease in vaccination rates has likely resulted in increased rates of measles in Texas…

  4

  1 条评论
• The value of knowing is not always positive

  2025年3月3日

  The value of knowing is not always positive

  An interesting article by Ciancio et al. (2025) which examines the impact of learning one has HIV when no treatment is…

  12

  1 条评论

Show more

See all articles